Descriptions
Autoinhibitory domains (AIDs)
Target domain |
952-1139 (P-loop containing nucleoside triphosphate hydrolase domain) |
Relief mechanism |
Partner binding |
Assay |
|
Accessory elements
No accessory elements
References
- Coleman DE et al. (1999) "Structure of Gialpha1.GppNHp, autoinhibition in a galpha protein-substrate complex", The Journal of biological chemistry, 274, 16669-72
- Lutz S et al. (2007) "Structure of Galphaq-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs", Science (New York, N.Y.), 318, 1923-7
Autoinhibited structure

Activated structure

1 structures for Q63803
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q63803-F1 | Predicted | AlphaFoldDB |
No variants for Q63803
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for Q63803 |
No associated diseases with Q63803
15 GO annotations of cellular component
Name | Definition |
---|---|
apical plasma membrane | The region of the plasma membrane located at the apical end of the cell. |
COPI-coated Golgi to ER transport vesicle | A vesicle that mediates transport from the Golgi to the endoplasmic reticulum. |
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
dendrite | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
endosome | A vacuole to which materials ingested by endocytosis are delivered. |
heterotrimeric G-protein complex | Any of a family of heterotrimeric GTP-binding and hydrolyzing proteins; they belong to a superfamily of GTPases that includes monomeric proteins such as EF-Tu and RAS. Heterotrimeric G-proteins consist of three subunits; the alpha subunit contains the guanine nucleotide binding site and possesses GTPase activity; the beta and gamma subunits are tightly associated and function as a beta-gamma heterodimer; extrinsic plasma membrane proteins (cytoplasmic face) that function as a complex to transduce signals from G protein-coupled receptors to an effector protein. |
membrane | A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it. |
neuronal cell body | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
recycling endosome | An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane. |
ruffle | Projection at the leading edge of a crawling cell; the protrusions are supported by a microfilament meshwork. |
trans-Golgi network membrane | The lipid bilayer surrounding any of the compartments that make up the trans-Golgi network. |
17 GO annotations of molecular function
Name | Definition |
---|---|
adenylate cyclase activator activity | Binds to and increases the activity of adenylate cyclase. |
adenylate cyclase regulator activity | Binds to and modulates the activity of adenylate cyclase. |
alpha-tubulin binding | Binding to the microtubule constituent protein alpha-tubulin. |
beta-2 adrenergic receptor binding | Binding to a beta-2 adrenergic receptor. |
corticotropin-releasing hormone receptor 1 binding | Binding to a corticotropin-releasing hormone receptor 1 (CRHR1). CRHR1 is the major subtype in the pituitary corticotroph, and mediates the stimulatory actions of corticotropin-releasing hormone on corticotropin hormone secretion. CRHR1 are also located in cortical areas of the brain, cerebellum and limbic system. |
D1 dopamine receptor binding | Binding to a D1 dopamine receptor. |
G protein activity | A molecular function regulator that cycles between active GTP-bound and inactive GDP-bound states. In its active state, binds to a variety of effector proteins to regulate cellular processes. Intrinsic GTPase activity returns the G protein to its GDP-bound state. The return to the GDP-bound state can be accelerated by the action of a GTPase-activating protein (GAP). |
G-protein alpha-subunit binding | Binding to a G-protein alpha subunit. The alpha subunit binds a guanine nucleotide. |
G-protein beta-subunit binding | Binding to a G-protein beta subunit. |
G-protein beta/gamma-subunit complex binding | Binding to a complex of G-protein beta/gamma subunits. |
GTP binding | Binding to GTP, guanosine triphosphate. |
GTPase activity | Catalysis of the reaction |
insulin-like growth factor receptor binding | Binding to an insulin-like growth factor receptor. |
ionotropic glutamate receptor binding | Binding to an ionotropic glutamate receptor. Ionotropic glutamate receptors bind glutamate and exert an effect through the regulation of ion channels. |
metal ion binding | Binding to a metal ion. |
mu-type opioid receptor binding | Binding to a mu-type opioid receptor. |
protein domain specific binding | Binding to a specific domain of a protein. |
38 GO annotations of biological process
Name | Definition |
---|---|
adenylate cyclase-activating adrenergic receptor signaling pathway | An adenylate cyclase-activating G protein-coupled receptor signaling pathway initiated by a ligand binding to an adrenergic receptor on the surface of the target cell, and ending with the regulation of a downstream cellular process. |
adenylate cyclase-activating dopamine receptor signaling pathway | An adenylate cyclase-activating G protein-coupled receptor signaling pathway initiated by dopamine binding to its receptor, and ending with the regulation of a downstream cellular process. |
adenylate cyclase-activating G protein-coupled receptor signaling pathway | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of adenylyl cyclase activity and a subsequent increase in the intracellular concentration of cyclic AMP (cAMP). |
bone development | The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components. |
cartilage development | The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate. |
cellular response to glucagon stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucagon stimulus. |
cognition | The operation of the mind by which an organism becomes aware of objects of thought or perception; it includes the mental activities associated with thinking, learning, and memory. |
developmental growth | The increase in size or mass of an entire organism, a part of an organism or a cell, where the increase in size or mass has the specific outcome of the progression of the organism over time from one condition to another. |
embryonic cranial skeleton morphogenesis | The process in which the anatomical structures of the cranial skeleton are generated and organized during the embryonic phase. |
embryonic hindlimb morphogenesis | The process, occurring in the embryo, by which the anatomical structures of the hindlimbs are generated and organized. The hindlimbs are the posterior limbs of an animal. |
endochondral ossification | Replacement ossification wherein bone tissue replaces cartilage. |
energy reserve metabolic process | The chemical reactions and pathways by which a cell derives energy from stored compounds such as fats or glycogen. |
G protein-coupled receptor signaling pathway | The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane. |
genomic imprinting | The establishment of epigenetic modifications (imprints) during gametogenesis, leading to an asymmetry between the maternal and paternal alleles, leading to differential expression of the corresponding alleles. This can happen through heterochromatin formation or through differential chromatin loop formation. |
hair follicle placode formation | The developmental process in which a hair placode forms. An hair follicle placode is a thickening of the ectoderm that will give rise to the hair follicle bud. |
multicellular organism growth | The increase in size or mass of an entire multicellular organism, as opposed to cell growth. |
negative regulation of blood pressure | Any process in which the force of blood traveling through the circulatory system is decreased. |
negative regulation of multicellular organism growth | Any process that stops, prevents, or reduces the frequency, rate or extent of growth of an organism to reach its usual body size. |
platelet aggregation | The adhesion of one platelet to one or more other platelets via adhesion molecules. |
positive regulation of cAMP-mediated signaling | Any process which activates, maintains or increases the frequency, rate or extent of cAMP-mediated signaling. |
positive regulation of cell population proliferation | Any process that activates or increases the rate or extent of cell proliferation. |
positive regulation of cold-induced thermogenesis | Any process that activates or increases the frequency, rate or extent of cold-induced thermogenesis. |
positive regulation of insulin secretion | Any process that activates or increases the frequency, rate or extent of the regulated release of insulin. |
positive regulation of osteoblast differentiation | Any process that activates or increases the frequency, rate or extent of osteoblast differentiation. |
positive regulation of osteoclast differentiation | Any process that activates or increases the frequency, rate or extent of osteoclast differentiation. |
positive regulation of protein phosphorylation | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
positive regulation of sodium ion transport | Any process that increases the frequency, rate or extent of the directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
post-embryonic body morphogenesis | The process in which the anatomical structures of the post-embryonic soma are generated and organized. |
post-embryonic development | The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development. |
regulation of parathyroid hormone secretion | Any process that modulates the frequency, rate or extent of parathyroid hormone secretion. |
regulation of signal transduction | Any process that modulates the frequency, rate or extent of signal transduction. |
regulation of transcription by RNA polymerase II | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. |
response to parathyroid hormone | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a parathyroid hormone stimulus. |
response to xenobiotic stimulus | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. |
sensory perception of chemical stimulus | The series of events required for an organism to receive a sensory chemical stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process. |
skeletal system development | The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton). |
skin development | The process whose specific outcome is the progression of the skin over time, from its formation to the mature structure. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner vascular dermis (cutis, corium or true skin) composed mostly of connective tissue. |
tissue homeostasis | A homeostatic process involved in the maintenance of an internal steady state within a defined tissue of an organism, including control of cellular proliferation and death and control of metabolic function. |
23 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
P04896 | GNAS | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Bos taurus (Bovine) | PR |
P63091 | GNAS | Guanine nucleotide-binding protein G(s) subunit alpha | Canis lupus familiaris (Dog) (Canis familiaris) | PR |
P38405 | GNAL | Guanine nucleotide-binding protein G | Homo sapiens (Human) | SS |
P29797 | GNAS | Guanine nucleotide-binding protein G(s) subunit alpha | Sus scrofa (Pig) | PR |
P93564 | GPA1 | Guanine nucleotide-binding protein alpha-1 subunit | Solanum tuberosum (Potato) | SS |
P38406 | Gnal | Guanine nucleotide-binding protein G | Rattus norvegicus (Rat) | SS |
Q63210 | Gna12 | Guanine nucleotide-binding protein subunit alpha-12 | Rattus norvegicus (Rat) | SS |
P19627 | Gnaz | Guanine nucleotide-binding protein G | Rattus norvegicus (Rat) | SS |
P29348 | Gnat3 | Guanine nucleotide-binding protein G | Rattus norvegicus (Rat) | SS |
O88302 | Gna15 | Guanine nucleotide-binding protein subunit alpha-15 | Rattus norvegicus (Rat) | SS |
Q9JID2 | Gna11 | Guanine nucleotide-binding protein subunit alpha-11 | Rattus norvegicus (Rat) | SS |
P82471 | Gnaq | Guanine nucleotide-binding protein G | Rattus norvegicus (Rat) | SS |
P04897 | Gnai2 | Guanine nucleotide-binding protein G | Rattus norvegicus (Rat) | SS |
P59215 | Gnao1 | Guanine nucleotide-binding protein G | Rattus norvegicus (Rat) | SS |
P08753 | Gnai3 | Guanine nucleotide-binding protein G | Rattus norvegicus (Rat) | SS |
Q6Q7Y5 | Gna13 | Guanine nucleotide-binding protein subunit alpha-13 | Rattus norvegicus (Rat) | SS |
P10824 | Gnai1 | Guanine nucleotide-binding protein G subunit alpha-1 | Rattus norvegicus (Rat) | EV |
Q0DJ33 | GPA1 | Guanine nucleotide-binding protein alpha-1 subunit | Oryza sativa subsp. japonica (Rice) | SS |
P49084 | GPA1 | Guanine nucleotide-binding protein alpha-1 subunit | Glycine max (Soybean) (Glycine hispida) | SS |
P93163 | GPA2 | Guanine nucleotide-binding protein alpha-2 subunit | Glycine max (Soybean) (Glycine hispida) | SS |
O80462 | XLG1 | Extra-large guanine nucleotide-binding protein 1 | Arabidopsis thaliana (Mouse-ear cress) | PR |
P18064 | GPA1 | Guanine nucleotide-binding protein alpha-1 subunit | Arabidopsis thaliana (Mouse-ear cress) | SS |
P26981 | GPA1 | Guanine nucleotide-binding protein alpha-1 subunit | Solanum lycopersicum (Tomato) (Lycopersicon esculentum) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MGMLNCLHGN | NMSGQHDIPP | EVGDQPEQEP | LEAQGAAAPG | AGVGPAEEME | TEPSNNEPIP |
70 | 80 | 90 | 100 | 110 | 120 |
DETDSEVCGP | PEDSKSDIQS | PSQAFEEVQV | GGDYSPPPEE | AMPFEIQQPS | LGDFWPTLEQ |
130 | 140 | 150 | 160 | 170 | 180 |
PGPSGTPSGI | KAFNPAILEP | GTPTGAHPGL | GAYSPPPEEA | MPFEFNEPAQ | EDRCQPPLQV |
190 | 200 | 210 | 220 | 230 | 240 |
PDLAPGGPEA | WVSRALPAEP | GNLGFENTGF | REDYSPPPEE | SVPFQLDGEE | FGGDSPPPGL |
250 | 260 | 270 | 280 | 290 | 300 |
PRVTPQIGIG | GEFPTVAVPS | TLCLAPAANA | PPLWVQGAIG | RPFREAVRSP | NFAYDISPME |
310 | 320 | 330 | 340 | 350 | 360 |
ITRPLLEIGR | ASTGVDDDTA | VNMDSPPIAS | DGPPIEVSGA | PVKSEHAKRP | PLERQAAETG |
370 | 380 | 390 | 400 | 410 | 420 |
NSPISSTTAE | EAKVPSLERG | EGSPTQPETV | HIKPAPVAES | GTDSSKADPD | SATHAVLQIG |
430 | 440 | 450 | 460 | 470 | 480 |
PEEVGGVPTM | PTDLPPASED | AGPDVRAEPD | GGTAPATPAE | SEDNREPAAA | AAAEPAAEPA |
490 | 500 | 510 | 520 | 530 | 540 |
AEPAAEPAAE | PAAEPAAEAV | PDTEAESASG | AVPDTQEEPA | AAAASATPAE | PAARAAPVTP |
550 | 560 | 570 | 580 | 590 | 600 |
TEPATRAVPS | ARAHPAAGAV | PGASAMSAAA | RAAAARAAYA | GPLVWGARSL | SATPAARASL |
610 | 620 | 630 | 640 | 650 | 660 |
PARAAAAARA | ASAARAVAAG | RSASAAPSRA | HLRPPSPEIQ | VADPPTPRPA | PRPSAWPDKY |
670 | 680 | 690 | 700 | 710 | 720 |
ERGRSCCRYE | AASGICEIES | SSDESEEGAT | GCFQWLLRRN | RRPGQPRSHT | VGSNPVRNFF |
730 | 740 | 750 | 760 | 770 | 780 |
ARAFGSCFGL | SECTRSRSLS | PGKAKDPMEE | RRKQMRKEAM | EMREQKRADK | KRSKLIDKQL |
790 | 800 | 810 | 820 | 830 | 840 |
EEEKMDYMCT | HRLLLLGAGE | SGKSTIVKQM | RILHVNGFNG | EGGEEDPQAA | RSNSDGEKAT |
850 | 860 | 870 | 880 | 890 | 900 |
KVQDIKNNLK | EAIETIVAAM | SNLVPPVELA | NPENQFRVDY | ILSVMNVPNF | DFPPEFYEHA |
910 | 920 | 930 | 940 | 950 | 960 |
KALWEDEGVR | ACYERSNEYQ | LIDCAQYFLD | KIDVIKQADY | VPSDQDLPRC | RVLTSGIFET |
970 | 980 | 990 | 1000 | 1010 | 1020 |
KFQVDKVNFH | MFDVGGQRDE | RRKWIQCFND | VTAIIFVVAS | SSYNMVIRED | NQTNRLQEAL |
1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
NLFKSIWNNR | WLRTISVILF | LNKQDLLAEK | VLAGKSKIED | YFPEFARYTT | PEDATPEPGE |
1090 | 1100 | 1110 | 1120 | 1130 | 1140 |
DPRVTRAKYF | IRDEFLRIST | ASGDGRHYCY | PHFTCAVDTE | NIRRVFNDCR | DIIQRMHLRQ |
YELL |